会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Detection of malignant tumor cells
    • 检测恶性肿瘤细胞
    • US5866690A
    • 1999-02-02
    • US487345
    • 1995-06-07
    • Samuel Bogoch
    • Samuel Bogoch
    • G01N33/574A61K38/00A61K39/395A61P35/00C07K1/22C07K14/005C07K14/195C07K16/00C07K16/30C12N5/08C12N5/10C12N15/09C12P21/00C12R1/91G01N33/577
    • C07K16/30A61K38/00
    • Described herein is the production of two products which are distinct species of human anti-malignin antibody, and the production of a cell line which has the distinguishing characteristic of manufacturing both species of anti-malignin antibody at different times. These anti-malignin products are useful to detect the presence of cancerous or malignant tumor cells. Additionally, these anti-malignin products preferentially attach to cancerous or malignant tumor cells in cell collections in vitro or in vivo and thus can be detected by any visible or other signal emitter attached to said anti-malignin product. This preferential attachment to malignant tumor cells also makes these products useful for metabolic and therapeutic purposes with or without an attached cytotoxic agent.
    • 本文描述了两种不同种类的人类抗恶性肿瘤抗体的产品的生产,以及具有在不同时间制造两种抗恶性肿瘤抗体的区别特征的细胞系的生产。 这些抗恶性肿瘤产品可用于检测癌细胞或恶性肿瘤细胞的存在。 此外,这些抗恶性肿瘤产品在体外或体内优先附着于细胞集合中的癌细胞或恶性肿瘤细胞,因此可通过附着于所述抗恶性肿瘤产品的任何可见或其他信号发射体来检测。 恶性肿瘤细胞的这种优先依附也使得这些产品在有或没有附着的细胞毒性剂的情况下可用于代谢和治疗目的。